Papers Unplugged: Precision Medicine in AML

[This is a Rerelease. Episode first published on November 1, 2024.]Join us for an engaging episode with Dr. Stephen Hibbs from Queen Mary University of London as he discusses the environmental impacts of hematology. Alongside our host Dr. Sarah de Vlieger, they explore how climat ...  Show more

[This is a Rerelease. Episode first published on April 11, 2025.]Listen to Dr. Jan Moritz Middeke from University Hospital in Dresden as he discusses the future of clinical trials in hematology and the role artificial intelligence (AI) may play in that field. Dr. Middeke explains ...  Show more

In this episode of the EADV Podcast, host Dr. Sarah Walsh sits down with Prof. Thrasivoulos Tzellos during the 2025 EADV Spring Symposium in Prague to discuss the latest European guidelines for the treatment of hidradenitis suppurativa (HS).

Together, they explore the e ...

In this episode, Dr. Nazim Gherabi (DZ) discusses his systematic review on the treatment of urge incontinence in postmenopausal women.

Dr. Gherabi talks about the most effective therapeutic approaches, and evaluates current evidence. He highlights gaps in research and ...

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ...  Show more

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...